Compound reference
TB-500 (Thymosin BETA-4)
Tissue & Repair Research · vial. For laboratory research use only. Not for human or veterinary consumption, diagnostic use, therapeutic use, or clinical use.
Chemistry identity
Reference identifiers
COA documentation
Lot record status
COA on file - lab confirmation pendingView Lab ReportsPublished literature
Research context
Peer-reviewed literature referencing this compound, provided for research context.
Engineered Tandem Thymosin Peptide Promotes Corneal Wound Healing2025
Nguyen J, Verma S, Vuong VT, Queener H, Coulson-Thomas VJ, Gesteira TF
Investigative ophthalmology & visual science
Researchers engineered a tandem TB4 peptide (tTB4) fusing two TB4 monomers into dual G-actin binding domains and compared it to native TB4 in cultured human corneal epithelial cells and a murine alkali-induced corneal injury model. The engineered peptide increased actin polymerization, cell viability, and migration in vitro, and produced greater wound closure with reduced scarring than native TB4 in the mouse model, illustrating how actin-binding-domain engineering shapes TB4's mechanism of action in epithelial repair research.
Tβ4-Engineered ADSC Extracellular Vesicles Rescue Cell Senescence Through Separable Microneedle Patches for Diabetic Wound Healing2025
Ding Y, Wang J, Li J, Cheng Y, Zhou S, Zhang Y, et al.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
In a rat diabetic wound model, investigators delivered TB4-engineered adipose-derived stem cell extracellular vesicles via dissolvable microneedle patches. The approach reduced markers of cellular senescence and modulated the PTEN/PI3K/AKT signaling pathway, improving wound-closure kinetics in the animal model relative to controls.
In Vitro Study of Thymosin Beta 4 Promoting Transplanted Fat Survival by Regulating Adipose-Derived Stem Cells2024
Li W, Yang Y, Lin Y, Mu D
Aesthetic plastic surgery
Using adipose-derived stem cells isolated from human liposuction samples, this in vitro study found TB4 exposure increased proliferation and migration and reduced apoptosis of the cells, with concurrent changes in angiogenesis-related and Hippo-pathway gene expression, indicating a mechanistic role for TB4 in regulating stem-cell behavior in graft-survival research models.
Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications2012
Goldstein AL, Hannappel E, Sosne G, Kleinman HK
Expert opinion on biological therapy
This foundational review synthesizes early mechanistic work showing that TB4, released by platelets and macrophages after injury, binds actin to promote cell migration and the mobilization of stem/progenitor cells contributing to new vessel formation, and describes evidence that TB4 reduces myofibroblast numbers and fibrosis in animal wound models -- establishing the actin-binding mechanism underlying its regenerative research applications in skin, cornea, heart, and CNS injury models.
Thymosin beta-4 is essential for coronary vessel development and promotes neovascularization via adult epicardium2007
Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, Chien KR, et al.
Annals of the New York Academy of Sciences
Using mouse coronary vessel development and adult epicardial explant models, this landmark study showed that TB4, an actin monomer-binding protein secreted from myocardium, provides a paracrine signal driving epicardium-derived progenitor cells to migrate inward and differentiate into endothelial and smooth-muscle lineages forming coronary vasculature, identifying TB4-driven epicardial reactivation as a mechanism underlying neovascularization research in the adult heart.
Catalog access requires an account and acceptance of a research-use disclaimer.
This product is intended strictly for research and laboratory use only. It is designated for in vitro testing and experimental purposes. Any use involving human or animal consumption is prohibited by law. All information provided on this website is for educational purposes only. This product must only be handled by licensed, qualified professionals. It is not intended for use as a drug, food, or cosmetic, and must not be misused, mislabeled, or misrepresented as such.


